11th Circ. Backs Pfizer Unit's Win Over False Ad Suit
The Eleventh Circuit on Thursday backed a lower court's rejection of a false advertising suit over Hospira's labeling of its epinephrine products, finding that competitor Belcher Pharmaceuticals failed to provide evidence...To view the full article, register now.
Already a subscriber? Click here to view full article